Macroprolactinemia: Diagnostic, clinical, and pathogenic significance

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Shimatsu, Akira ^a   Hattori, Naoki ^b  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AUTOANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MACROGOL; PROLACTIN; PROLACTIN I 125; PROTEIN A; PROTEIN G; PROLACTIN RECEPTOR; PROLACTIN, POLYMERIC;

AUTOIMMUNE DISEASE; BINDING SITE; CROSS REACTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FOLLOW UP; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPERPROLACTINEMIA; LONG TERM CARE; MACROPROLACTINEMIA; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; REVIEW; ANIMAL; BLOOD; IMMUNOLOGY;

ANIMALS; AUTOANTIBODIES; HUMANS; HYPERPROLACTINEMIA; IMMUNOGLOBULIN G; PROLACTIN; RECEPTORS, PROLACTIN;

MLCS; MLOWN;

EID: 84871358768     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/167132     Document Type: Review

References (47)

1. Freeman M. E., Kanyicska B., Lerant A., Nagy G., Prolactin: structure, function, and regulation of secretion. Physiological Reviews 2000 80 1523 1631 2-s2.0-0033771336
2. Shelly S., Boaz M., Orbach H., Prolactin and autoimmunity. Autoimmunity Reviews 2012 11 6-7 A465 A470 10.1016/j.autrev.2011.11.009
3. Molitch M. E., Pathologic hyperprolactinemia. Endocrinology and Metabolism Clinics of North America 1992 21 4 877 901 2-s2.0-0026676389 (Pubitemid 23005089)
4. Berinder K., Stackenäs I., Akre O., Hirschberg A. L., Hulting A. L., Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Clinical Endocrinology 2005 63 4 450 455 2-s2.0-26644442552 10.1111/j.1365-2265. 2005.02364.x (Pubitemid 41442340)
5. Hattori N., Ishihara T., Ikekubo K., Moridera K., Hino M., Kurahachi H., Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism 1992 75 5 1226 1229 2-s2.0-0026475390 10.1210/jc.75.5.1226
6. Burch H. B., Clement S., Sokol M. S., Landry F., Reactive hypoglycemic coma due to insulin autoimmune syndrome: case report and literature review. The American Journal of Medicine 1992 92 6 681 685 2-s2.0-0026634636 10.1016/0002-9343(92)90787-C
7. Sanke T., Kondo M., Moriyama Y., Nanjo K., Iwo K., Miyamura K., Glucagon binding autoantibodies in a patient with hyperthyroidism treated with methimazole. Journal of Clinical Endocrinology and Metabolism 1983 57 6 1140 1144 2-s2.0-0021013608 (Pubitemid 14209410)
8. Sakata S., Nakamura S., Miura K., Autoantibodies against thyroid hormones or iodothyronine: implications in diagnosis, thyroid function, treatment, and pathogenesis. Annals of Internal Medicine 1985 103 4 579 589 2-s2.0-0022134521
9. Cavaco B., Leite V., Loureiro M. M., Ferreira M. F., Pereira M. C., Santos M. A., Sobrinho L. G., Spontaneously occurring anti-PTH autoantibodies must be considered in the differential diagnosis of patients with elevated serum PTH levels. Journal of Endocrinological Investigation 1999 22 11 829 834 2-s2.0-0033389768 (Pubitemid 30083174)
10. Wheatland R., Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. Medical Hypotheses 2005 65 2 287 295 2-s2.0-19744372384 10.1016/j.mehy.2005.02.031 (Pubitemid 40744756)
11. Meyer W. R., Lavy G., DeCherney A. H., Visintin I., Economy K., Luborsky J. L., Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstetrics and Gynecology 1990 75 5 795 799 2-s2.0-0025360960 (Pubitemid 20139160)
12. Wilkin T. J., Voss L., Tuck A., Bullen H., Betts P., Autoantibodies to endogenous growth hormone in short children (The Wessex Growth Study). Autoimmunity 1992 14 1 67 72 2-s2.0-0027058032 (Pubitemid 23103793)
13. Lazarus J. H., John R., Ginsberg J., Transient neonatal hyperthyrotrophinaemia: a serum abnormality due to transplacentally acquired antibody to thyroid stimulating hormone. British Medical Journal 1983 286 6365 592 594 2-s2.0-0020674925 (Pubitemid 13144846)
14. Fetissov S. O., Harro J., Jaanisk M., Järv A., Podar I., Allik J., Nilsson I., Sakthivel P., Lefvert A. K., Hökfelt T., Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proceedings of the National Academy of Sciences of the United States of America 2005 102 41 14865 14870 2-s2.0-26844545833 10.1073/pnas.0507204102 (Pubitemid 41457147)
15. Hattori N., Ishihara T., Saiki Y., Shimatsu A., Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. Clinical Endocrinology 2010 73 6 792 797 2-s2.0-78649235625 10.1111/j.1365-2265.2010.03880.x
16. Hattori N., Ikekubo K., Ishihara T., Moridera K., Hino M., Kurahachi H., A normal ovulatory woman with hyperprolactinemia: presence of anti-prolactin autoantibody and the regulation of prolactin secretion. Acta Endocrinologica 1992 126 6 497 500
17. Hattori N., Ishihara T., Saiki Y., Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clinical Endocrinology 2009 71 5 702 708 2-s2.0-70349678935 10.1111/j.1365-2265.2009.03570.x
18. Hattori N., Inagaki C., Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. Journal of Clinical Endocrinology and Metabolism 1997 82 9 3107 3110 2-s2.0-0030883935 10.1210/jc.82.9.3107 (Pubitemid 27385683)
19. Vieira J. G. H., Tachibana T. T., Obara L. H., Maciel R. M. B., Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clinical Chemistry 1998 44 8 I 1758 1759 2-s2.0-0031874910 (Pubitemid 28381226)
20. Fahie-Wilson M. N., Soule S. G., Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Annals of Clinical Biochemistry 1997 34 3 252 258 2-s2.0-0030913715 (Pubitemid 27236927)
21. Leslie H., Courtney C. H., Bell P. M., Hadden D. R., Mccance D. R., Ellis P. K., Sheridan B., Atkinson A. B., Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. Journal of Clinical Endocrinology and Metabolism 2001 86 6 2743 2746 2-s2.0-0034975883 10.1210/jc.86.6.2743 (Pubitemid 32545732)
22. Vallette-Kasic S., Morange-Ramos I., Selim A., Gunz G., Morange S., Enjalbert A., Martin P. M., Jaquet P., Brue T., Macroprolactinemia revisited: a study on 106 patients. Journal of Clinical Endocrinology and Metabolism 2002 87 2 581 588 2-s2.0-0036174473 10.1210/jc.87.2.581 (Pubitemid 34158222)
23. Gibney J., Smith T. P., McKenna T. J., The impact on clinical practice of routine screening for macroprolactin. Journal of Clinical Endocrinology and Metabolism 2005 90 7 3927 3932 2-s2.0-23044490138 10.1210/jc.2004-2234 (Pubitemid 41058153)
24. Cavaco B., Leite V., Santos M. A., Arranhado E., Sobrinho L. G., Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma. Journal of Clinical Endocrinology and Metabolism 1995 80 8 2342 2346 2-s2.0-0029093545
25. De Schepper J., Schiettecatte J., Velkeniers B., Blumenfeld Z., Shteinberg M., Devroey P., Anckaert E., Smitz J., Verdood P., Hooghe R., Hooghe-Peters E., Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. European Journal of Endocrinology 2003 149 3 201 207 2-s2.0-0141851232 10.1530/eje.0.1490201 (Pubitemid 37120992)
26. Kavanagh L., McKenna T. J., Fahie-Wilson M. N., Gibney J., Smith T. P., Specificity and clinical utility of methods for the detection of macroprolactin. Clinical Chemistry 2006 52 7 1366 1372 2-s2.0-33745459047 10.1373/clinchem. 2005.065854 (Pubitemid 43956029)
27. Gibney J., Smith T. P., McKenna T. J., Clinical relevance of macroprolactin. Clinical Endocrinology 2005 62 6 633 643 2-s2.0-20444474991 10.1111/j.1365-2265.2005.02243.x (Pubitemid 40825930)
28. Smith T. P., Suliman A. M., Fahie-Wilson M. N., McKenna T. J., Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. Journal of Clinical Endocrinology and Metabolism 2002 87 12 5410 5415 2-s2.0-0036929287 10.1210/jc.2001-011943 (Pubitemid 36034335)
29. Hattori N., The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. Journal of Clinical Endocrinology and Metabolism 1996 81 2 586 590 2-s2.0-0030019671 10.1210/jc.81.2.586 (Pubitemid 26055668)
30. Suh H. K., Frantz A. G., Size heterogeneity of human prolactin in plasma and pituitary extracts. Journal of Clinical Endocrinology and Metabolism 1974 39 5 928 935 2-s2.0-0016261540
31. Akerstrom B., Bjorck L., A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties. Journal of Biological Chemistry 1986 261 22 10240 10247 2-s2.0-0022845301 (Pubitemid 17221958)
32. Hattori N., Nakayama Y., Kitagawa K., Ishihara T., Saiki Y., Inagaki C., Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia. Clinical Endocrinology 2008 68 1 72 76 2-s2.0-36949003690 10.1111/j.1365-2265.2007.03001.x (Pubitemid 350243484)
33. Hattori N., Ikekubo K., Ishihara T., Moridera K., Hino M., Kurahachi H., Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. European Journal of Endocrinology 1994 130 5 438 445 2-s2.0-0028340831 (Pubitemid 24165768)
34. Wallace I. R., Satti N., Courtney C. H., Leslie H., Bell P. M., Hunter S. J., McCance D. R., Sheridan B., Atkinson A. B., Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. Journal of Clinical Endocrinology and Metabolism 2010 95 7 3268 3271 2-s2.0-77954910025 10.1210/jc.2010-0114
35. Malarkey W. B., Jackson R., Wortsman J., Long-term assessment of patients with macroprolactinemia. Fertility and Sterility 1988 50 3 413 418 2-s2.0-0023682628
36. Leite V., Cosby H., Sobrinho L. G., Fresnoza A., Santos M. A., Friesen H. G., Characterization of big, big prolactin in patients with hyperprolactinaemia. Clinical Endocrinology 1992 37 4 365 372 2-s2.0-0026787410
37. Leaños-Miranda A., Pascoe-Lira D., Chávez-Rueda K. A., Blanco-Favela F., Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia. Lupus 2001 10 5 340 345 2-s2.0-0034990783 10.1191/096120301672772070 (Pubitemid 32520240)
38. Kavanagh-Wright L., Smith T. P., Gibney J., McKenna T. J., Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clinical Endocrinology 2009 70 4 599 605 2-s2.0-61449139247 10.1111/j.1365-2265.2008.03402.x
39. Hattori N., Nakayama Y., Kitagawa K., Ishihara T., Saiki Y., Inagaki C., Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia. Journal of Endocrinology 2006 190 2 287 293 2-s2.0-33747878491 10.1677/joe.1.06871 (Pubitemid 44288366)
40. Hattori N., Ikekubo K., Nakaya Y., Kitagawa K., Inagaki C., Immunoglobulin G subclasses and prolactin (PRL) isoforms in macroprolactinemia due to anti-PRL autoantibodies. Journal of Clinical Endocrinology and Metabolism 2005 90 5 3036 3044 2-s2.0-18844428029 10.1210/jc.2004-1600 (Pubitemid 40686361)
41. Hattori N., Nakayama Y., Kitagawa K., Li T., Inagaki C., Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia. Endocrinology 2007 148 5 2465 2470 2-s2.0-34249785979 10.1210/en.2006-1208 (Pubitemid 46997039)
42. Glezer A., Soares C. R. J., Vieira J. G., Giannella-Neto D., Ribela M. T. C. P., Goffin V., Bronstein M. D., Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. Journal of Clinical Endocrinology and Metabolism 2006 91 3 1048 1055 2-s2.0-33644819532 10.1210/jc.2005-1831 (Pubitemid 43357779)
43. Leaños-Miranda A., Cárdenas-Mondragón G., Rivera-Leaños R., Ulloa-Aguirre A., Goffin V., Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients. Clinical Endocrinology 2006 65 2 146 153 2-s2.0-33746081742 10.1111/j.1365-2265. 2006.02548.x (Pubitemid 44079675)
44. Teilum K., Hoch J. C., Goffin V., Kinet S., Martial J. A., Kragelund B. B., Solution structure of human prolactin. Journal of Molecular Biology 2005 351 4 810 823 2-s2.0-23444431656 10.1016/j.jmb.2005.06.042 (Pubitemid 41111898)
45. Marrack P., Kappler J., Kotzin B. L., Autoimmune disease: why and where it occurs. Nature Medicine 2001 7 8 899 905 2-s2.0-0034892128 10.1038/90935 (Pubitemid 32756426)
46. Ohara M., Hibi T., Watanabe N., Kobayashi K., Takaishi H., Hayashi A., Hosoda Y., Toda K., Iwao Y., Watanabe M., Aiso S., Tsuchiya T. M., Ishii H., Immunoglobulin G subclass distribution of human anticolon antibodies in ulcerative colitis. Journal of Gastroenterology and Hepatology 1995 10 2 158 164 2-s2.0-0028939938
47. Guido R., Valenti S., Foppiani L., De Martini D., Cossu M., Giusti M., Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma. Journal of Endocrinological Investigation 1997 20 5 289 293 2-s2.0-0030742365 (Pubitemid 27338848)